Lobbying disclosures · Lobbying report
ABT: second_quarter 2026 lobbying report
S.2003 The Strengthening Benefit Plans Act of 2025. Proposals related to The United States-Mexico-Canada Agreement (USMCA). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations. Proposals related to data privacy/data collection, usage and retention. S.2426/H.R.3164 Equitable Community Access to Pharmacist Services Act. S.4118/H.R.7966 The Hospice Care Accountability, Reform and Enforcement Act of 2026. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department
Follow ABT- Became public
- Jul 20, 2026, 4:41 PM EDT
- Event / period date
- Not stated
- Collected
- Nov 8, 2026, 9:48 AM EST
Why this is connected
Exact legal-name match: ABBOTT LABORATORIES (https://www.sec.gov/Archives/edgar/data/1800/).
Reported lobbying amounts
Expenses: $1,150,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/3e857be5-28c1-436f-93c8-35af921c0fa5/","filing_uuid":"3e857be5-28c1-436f-93c8-35af921c0fa5","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3e857be5-28c1-436f-93c8-35af921c0fa5/print/","filing_document_content_type":"text/html","income":null,"expenses":"1150000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Seth Radus","dt_posted":"2026-07-20T16:41:41-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"1801 PENNSYLVANIA AVENUE, NW","registrant_address_2":"SUITE 900","registrant_different_address":true,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20006","registrant":{"id":66,"url":"https://lda.gov/api/v1/registrants/66/","house_registrant_id":30001,"name":"ABBOTT LABORATORIES","description":null,"address_1":"1801 PENNSYLVANIA AVENUE, NW","address_2":"SUITE 900","address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20006","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"SETH RADUS","contact_telephone":"+1 202-378-2020","dt_updated":"2026-07-26T15:03:24.712043-04:00"},"client":{"id":100021,"url":"https://lda.gov/api/v1/clients/100021/","client_id":12,"name":"ABBOTT LABORATORIES","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"S.2003 The Strengthening Benefit Plans Act of 2025.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAR","general_issue_code_display":"Tariff (miscellaneous tariff bills)","description":"Proposals related to The United States-Mexico-Canada Agreement (USMCA). Proposals related to tariffs on products imported into the United States. Proposals regarding US-China trade negotiations.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152699,"prefix":null,"prefix_display":null,"first_name":"LYNN","nickname":null,"middle_name":null,"last_name":"SHA","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":1,"name":"SENATE"},{"id":12,"name":"White House Office"}]},{"general_issue_code":"CSP","general_issue_code_display":"Consumer Issues/Safety/Products","description":"Proposals related to data privacy/data collection, usage and retention.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"S.2426/H.R.3164 Equitable Community Access to Pharmacist Services Act. S.4118/H.R.7966 The Hospice Care Accountability, Reform and Enforcement Act of 2026. Proposals related to the advancement, testing and detection of Traumatic Brain Injury (TBI). Proposals related to Department of Defense coverage of continuous glucose monitors. Proposals related to digital health technologies and innovations. Proposals related to medical device cybersecurity. Proposals related to colorectal cancer screening. Proposals to support updates to the Veteran colorectal cancer screening directive. Proposals regarding the creation of quality measures for colorectal cancer screening.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152699,"prefix":null,"prefix_display":null,"first_name":"LYNN","nickname":null,"middle_name":null,"last_name":"SHA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65726,"prefix":null,"prefix_display":null,"first_name":"ASHLI","nickname":null,"middle_name":null,"last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":"(Employee of affiliated org. Exact Sciences Corporation.)","new":true},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Proposals related to Medicare coverage of continuous glucose monitors. Proposals related to the National Coverage Determination for colorectal cancer screening. Proposals related to the competitive bidding process. Proposals related to The RAPID (Regulatory Alignment for Predictable and Immediate Device) coverage pathway initiative for eligible Breakthrough Medical Devices.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152699,"prefix":null,"prefix_display":null,"first_name":"LYNN","nickname":null,"middle_name":null,"last_name":"SHA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":65726,"prefix":null,"prefix_display":null,"first_name":"ASHLI","nickname":null,"middle_name":null,"last_name":"DOUGLAS","suffix":null,"suffix_display":null},"covered_position":"(Employee of affiliated org. Exact Sciences Corporation.)","new":true},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Proposals related to U.S. global health programs and pandemic preparedness.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]},{"general_issue_code":"LAW","general_issue_code_display":"Law Enforcement/Crime/Criminal Justice","description":"Proposals related to third party litigation reform.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"FOO","general_issue_code_display":"Food Industry (safety, labeling, etc.)","description":"S.3387 - Ensuring Safe and Toxic-Free Foods Act of 2023. H.R.2300 To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes. H.R.9817 Toxic Free Food Act of 2024. H.R.4958 The Grocery Reform and Safety (GRAS) Act. Proposals related to infant formula ingredients. Proposals related to access to infant formula. Proposals related to oral nutrition supplements usage in hospital care settings.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":149747,"prefix":null,"prefix_display":null,"first_name":"BETH","nickname":null,"middle_name":null,"last_name":"NELSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152699,"prefix":null,"prefix_display":null,"first_name":"LYNN","nickname":null,"middle_name":null,"last_name":"SHA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":68934,"prefix":null,"prefix_display":null,"first_name":"SETH","nickname":null,"middle_name":"M","last_name":"RADUS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149748,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"APPLE","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":51302,"prefix":null,"prefix_display":null,"first_name":"THOMAS","nickname":null,"middle_name":null,"last_name":"EVERS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":58923,"prefix":null,"prefix_display":null,"first_name":"AUSTIN","nickname":null,"middle_name":null,"last_name":"BURNES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":69688,"prefix":null,"prefix_display":null,"first_name":"DEVON","nickname":null,"middle_name":"NICOLE","last_name":"FOLTZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in ABT
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Oct 30, 2026$1K–$15K
Rep. Thomas H. Kean, Jr. (R-NJ-7)
Sold (partial) Abbott Laboratories ABT
$1K–$15K · Traded Sep 17, 2026 · disclosed Oct 30, 2026
Committee overlap: Energy and Commerce - Oct 27, 2026$50K–$100K
Rep. Pete Sessions (R-TX-17)
$50K–$100K · Traded Oct 2, 2026 · disclosed Oct 27, 2026 · Spouse
- Oct 12, 2026$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 18, 2026 · disclosed Oct 12, 2026
- Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
Bought Abbott Laboratories ABT
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Aug 18, 2026$15K–$50K
Rep. Rick W. Allen (R-GA-12)
$15K–$50K · Traded Jul 14, 2026 · disclosed Aug 18, 2026 · Spouse
Committee overlap: Energy and CommerceTraded 2 days before earnings - Aug 14, 2026$1K–$15K
Rep. Richard McCormick (R-GA-7)
$1K–$15K · Traded Jul 30, 2026 · disclosed Aug 14, 2026
Got $2K from the company’s PAC - Aug 12, 2026$1K–$15K
Rep. Mike Kelly (R-PA-16)
$1K–$15K · Traded Jul 17, 2026 · disclosed Aug 12, 2026 · Spouse
- Jul 21, 2026$15K–$50K
Sen. Alan Armstrong (R-OK)
Sold (full) Abbott Laboratories ABT
$15K–$50K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.